{
    "nct_id": "NCT04469842",
    "official_title": "A Prospective, Randomized, Controlled Pilot Study of Early-Use Long Acting Tacrolimus (Envarsus XR) in Lung Transplant Recipients",
    "inclusion_criteria": "* Status-post single or bilateral lung transplantation\n* Participant is able to give informed consent for participation in the study.\n* Male or female age 18 years or above.\n* Actively receives care at VUMC and is adherent with medical therapies.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of prior organ transplantation\n* History of tacrolimus use prior to transplantation\n* Intolerance of tacrolimus (that precludes use)\n* Having DSA pre-transplant (Positive virtual crossmatch)\n* Active infection with Hepatitis B or C\n* Active infection with Human Immunodeficiency Virus (HIV)\n* Baseline AST / ALT > three times upper limit normal\n* Primary graft dysfunction grade 3 at 72 hours\n* Acute kidney injury during index hospitalization that does not resolve to two times the pre-transplant baseline value.\n* Contraindication to PO (per os) intake of medications\n* Impaired GI absorption (defined as sublingual administration of IR-tacro)\n* History of frequent headaches\n* Seizure history\n* Cannot provide consent (at least verbally)\n* Pregnancy or breast-feeding\n* Participation in another interventional clinical trial",
    "miscellaneous_criteria": ""
}